![Vitae Breast Cancer](/sites/default/files/styles/img_search_list_desktop/public/2021-10/VitaeBreastCancer-Argus_D8.jpg?h=d15dc50e&itok=4Lqy42bi)
SCOR a mis au point un calculateur du risque de récidive "Vitae Breast Cancer"
SCOR a mis au point un calculateur du risque de récidive "Vitae Breast Cancer"
SCOR enregistre un résultat net de EUR 339 millions démontrant sa capacité à absorber les chocs et lance un programme de rachat d’actions de EUR 200 millions
SCOR is revaluating the way we consider risk
Most of us will need long-term care at the end of our lives, yet it is one of the largest uninsured risks facing the elderly.
The 8th annual Global Consumer Study by ReMark, a SCOR Group company, sheds light on what consumers worldwide feel about health, AI, data privacy, and more.
The eighth Prize was awarded to Axel Montagne of the University of Edinburgh
A compelling and poignant look at some of the major events of the past year
Familial Hypercholesterolemia is the most common genetic disease worldwide
Supporting research and advancing knowledge